Classification of benign infantile afebrile seizures

Takuya Tanabe1, Keita Hara, Mitsuru Kashiwagi

  • 1Division of Pediatrics, Hirakata City Hospital, 2-14-1 Kinyahonmachi, Hirakata City, Osaka 573-1013, Japan. tanabemapa@pop01.odn.ne.jp

Epilepsy Research
|July 4, 2006
PubMed

Insights

This study classifies infantile benign seizures, finding that benign convulsions with mild gastroenteritis differ in onset age from benign partial epilepsy in infancy and benign infantile convulsions. Focal seizure initiation is observed in all cases, suggesting benign infantile convulsions may be a subtype of benign partial epilepsy in infancy.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Clinical Neuroscience

Background:

  • Accurate classification of infantile seizures is crucial for diagnosis and management.
  • Distinguishing between various benign infantile epilepsy syndromes can be challenging.
  • Understanding the clinical features associated with different seizure types aids in diagnosis.

Purpose of the Study:

  • To classify infantile cases of benign seizures into established epileptic syndromes.
  • To identify key clinical factors influencing the diagnosis of these syndromes.
  • To differentiate between benign convulsions with mild gastroenteritis, benign partial epilepsy in infancy, and benign infantile convulsions.

Main Methods:

  • Enrolled 57 infants with afebrile seizures, normal development, no underlying disorders, onset before age four, and normal interictal EEG/neuroimaging.
  • Classified patients into three groups: Group A (gastroenteritis association), Group B (partial seizures), and Group C (suspected generalized seizures).
  • Analyzed age at onset, seizure type, family history, seizure clustering, and response to lidocaine.

Main Results:

  • Thirty-nine cases (Group A) were associated with mild gastroenteritis, with a significantly later age at onset (19.5 months) compared to Group B (5.3 months) and Group C (5.8 months).
  • Thirteen cases had partial seizures (Group B), and five had suspected generalized seizures (Group C).
  • Positive family history, seizure clustering, and lidocaine efficacy were common across all groups.

Conclusions:

  • Group A features align with benign convulsions with mild gastroenteritis; Group B with benign partial epilepsy in infancy (BPEI); Group C with benign infantile convulsions (BIC).
  • Distinguishing features include age at onset, gastroenteritis association, and ictal symptomatology.
  • Ictal video-EEG monitoring revealed focal seizure initiation in all cases, suggesting BIC may be a subtype of BPEI, questioning the distinct identity of BIC.
Abstract

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Seizures ll: Types01:19

Seizures ll: Types

Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...